Full Text View
Tabular View
No Study Results Posted
Related Studies
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
This study is ongoing, but not recruiting participants.
Study NCT00568776   Information provided by Elan Pharmaceuticals
First Received: December 4, 2007   Last Updated: July 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alzheimer Disease
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
ELND005
Placebo Control
Additional drug interventions recognized in this trial
Inositol
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Elan Pharmaceuticals
Transition Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services